Related Experiment Video
Updated: May 18, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Sequence thyself: personalized medicine and therapies for the future: 2012 Yale Healthcare Conference
1School of Nursing, Yale University, New Haven, CT 06519, USA. ashley.clark@yale.edu
Abstract:
Now in its 8th year, the Yale Healthcare Conference has arguably come upon its most exciting and dramatic time within the U.S. health care system. Dynamic speakers from all over the country came together in April 2012 at Yale University to question, debate, creatively think, and examine challenges within health care organizations and institutions. One of the most prominent issues concerned the aftermath of sequencing the human genome and the explosion of information concerning gene polymorphisms and biomarkers in health and disease. Clinicians, scientists, and pharmaceuticals are looking to innovative individually tailored treatments for patients. During the conference breakout session, speakers Thomas Lynch, MD, director of the Yale Cancer Center and physician-in-chief of the Smilow Cancer Hospital, and Zen Chu, MBA, co-founder of Accelerated Medical Ventures and entrepreneur-in-residence at Massachusetts Institute of Technology, provided enriching discussion on the delivery of science and genetic care of the individual.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Gene Therapy
Gene Therapy
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Microorganisms in Medicine and Therapeutics

